Takafumi Yanagisawa

75PUBLICATIONS
129CO-AUTHORS
Predictive and prognostic markersHaematological tumoursNutritional epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (75)

|Sep 21, 2026
Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy.

|Sep 12, 2026
Machine learning integrated explainable artificial intelligence in predicting toxicities of enfortumab vedotin in urothelial carcinoma: an exploratory study.

|Sep 10, 2026
Perioperative Safety and Long-Term Oncological Outcomes of En Bloc Resection of Bladder Tumor: A Multicenter Real-World Study of 668 Patients.

|Aug 24, 2026
Diet and risk of bladder cancer: a systematic review of epidemiological evidence.

|Aug 08, 2026
Real-World Outcomes of Combination Therapy With Radium-223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer.

|Jun 12, 2026
From Genes to Proteins: The Indispensable Role of Proteogenomics in Advancing Clear Cell Renal Cell Carcinoma Research.

Pageof 13

Frequent Collaborators

30 joint publications

Takahiro Kimura

21 joint publications

Jun Miki

19 joint publications

Wataru Fukuokaya

18 joint publications

Ekaterina Laukhtina